Millions suffer with conditions that go undiagnosed, undertreated, or dismissed entirely. Brown Innovations & Solutions LLC builds AI tools that listen, remember, and help patients find the clarity they deserve.
Brown Innovations & Solutions LLC (Brown Innovations & Solutions) was founded by Doug Brown and Bruce Brown with a singular belief: the most advanced AI in the world should work for patients, not just hospitals.
After watching their family member spend five years misdiagnosed by the traditional medical system, they built an AI that did what no single doctor had done — it remembered everything, analyzed all the data holistically, and identified the correct diagnosis in days.
That experience became the foundation for two platforms now serving real patients and real needs.
Built on Claude by Anthropic — the most capable AI for medical reasoning and nuanced conversation.
Both platforms are actively used by real patients with complex conditions, not just demos.
AES-256-GCM encryption, zero admin access to health data, HIPAA-aligned architecture.
Surfaced MCAS as a diagnostic possibility after 5 years of inconclusive evaluations — with supporting lab data.
Purpose-built AI healthcare tools addressing a combined $125 billion market across mental health and medical diagnostics.
A comprehensive mental health platform with 47 evidence-based therapeutic tools for anxiety, PTSD, and crisis intervention. Features Luna, an AI companion that provides real-time support grounded in CBT, DBT, and exposure therapy protocols.
A personal AI medical companion that knows your complete health history and helps patients explore possibilities that may have been overlooked. Built for patients with complex, chronic, and rare conditions — with diagnostic intelligence that remembers everything.
The healthcare AI market is growing faster than any other sector in digital health. Companies with less clinical depth than ours have commanded multi-billion dollar valuations.
Healthcare AI companies with strong product-market fit and recurring revenue command 4–10x revenue multiples. The dual-platform approach — mental health and medical diagnostics under one company — is a positioning no competitor currently holds.
Large language models crossed the clinical reasoning threshold in 2024-2025. For the first time, AI can engage in medical-grade differential diagnosis — the core of Livaramed's value proposition.
The US will face a shortage of 160,000 mental health professionals by 2030. 40% of anxiety sufferers receive no treatment. Digital tools aren't optional — they're essential infrastructure.
Anxiety prevalence increased 25% since 2020 and hasn't returned to baseline. Telehealth adoption permanently shifted consumer expectations for digital healthcare access.
We compete in two large markets — and hold advantages that existing players don't.
| Feature | Calm | Woebot | NeuralCalm |
|---|---|---|---|
| AI Companion | -- | Yes | Yes |
| Crisis Intervention | -- | Limited | Yes |
| Evidence-Based Tools | 10+ | CBT only | 47 |
| PTSD-Specific | -- | -- | Yes |
| Privacy (No Data Selling) | -- | Yes | Yes |
| Biometric Integration | -- | -- | Planned |
| Feature | ChatGPT | K Health | Livaramed |
|---|---|---|---|
| Persistent Memory | -- | Limited | Full |
| Lab Result Analysis | Basic | -- | Deep |
| Differential Diagnosis | Generic | Yes | Contextual |
| Treatment Plans | -- | -- | Yes |
| Document Upload | Yes | -- | Yes |
| Full Health History Context | -- | -- | Yes |
Livaramed remembers every conversation, lab result, and symptom — building a complete patient profile no competitor matches.
Mental health + medical diagnostics under one company. No competitor addresses both sides of the patient experience.
Our AI surfaced a diagnostic possibility after 5 years of inconclusive evaluations — a real patient, real labs, real outcome.
A family member spent 5 years and 15+ doctor visits across multiple specialists — including the Mayo Clinic — without a unifying diagnosis. Labs were dismissed. Symptoms were treated in isolation. No one connected the dots.
Livaramed's AI ingested every lab result, every symptom log, every clinical note. It cross-referenced patterns across immunology, endocrinology, and gastroenterology. Within days, it identified Mast Cell Activation Syndrome (MCAS) as the unifying diagnosis — with supporting lab evidence that had been overlooked.
This wasn't a demo. It was a real patient, real labs, and a real outcome that changed a life. That's why we built this company.
Chronic fatigue, GI issues, anxiety episodes, unexplained reactions. Multiple ER visits. Each specialist treated their own silo.
Elevated WBC (11.5), ANA 1:160 Speckled, epinephrine 138 (68% above normal). Findings noted but not connected.
Livaramed ingests complete health history — every lab, symptom, medication, and clinical note across all providers.
AI cross-references all data points and identifies Mast Cell Activation Syndrome with supporting evidence from labs that had been individually dismissed.
A founding team with 58+ years of combined entrepreneurial, legal, and technology experience.
40 years of entrepreneurial experience building ventures in legal technology and digital marketing. Created StepparentAdoptionForms.com, helping over 25,000 families access affordable legal services. Track record of identifying underserved markets and building sustainable businesses.
Former practicing attorney and full-stack engineer with 18+ years of business strategy and technology leadership. Sole architect of both platforms — built NeuralCalm (47 tools, 93/100 audit) and Livaramed (persistent AI memory) from the ground up. Legal background provides critical regulatory and compliance expertise in digital health.
We welcome conversations with investors, strategic partners, healthcare organizations, and anyone who shares our vision for accessible AI healthcare.
Doug Brown, CEO Bruce Brown, J.D., CTO
info@brownias.com